title: Liraglutide in combination with acitretin for severe recalcitrant psoriasis.
authors.forename: C T
authors.initials: CT
authors.lastname: Reid
authors.forename: A M
authors.initials: AM
authors.lastname: Tobin
authors.forename: T
authors.initials: T
authors.lastname: Ahern
authors.forename: D
authors.initials: D
authors.lastname: O'Shea
authors.forename: B
authors.initials: B
authors.lastname: Kirby
mesh_terms: D017255:Acitretin / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D054795:Incretins / Q000627:therapeutic use*; D007641:Keratolytic Agents / Q000627:therapeutic use*; D000069450:Liraglutide; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D054795:Incretins; D007641:Keratolytic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1; D017255:Acitretin